Co-development of mesoderm and endoderm enables organotypic vascularization in lung and gut organoids
- PMID: 40592324
- DOI: 10.1016/j.cell.2025.05.041
Co-development of mesoderm and endoderm enables organotypic vascularization in lung and gut organoids
Abstract
The vasculature and mesenchyme exhibit distinct organ-specific characteristics adapted to local physiological needs, shaped by microenvironmental and cell-cell interactions from early development. To recapitulate this entire process, we co-differentiated mesoderm and endoderm within the same spheroid to vascularize lung and intestinal organoids from induced pluripotent stem cells (iPSCs). Bone morphogenetic protein (BMP) signaling fine-tuned the endoderm-to-mesoderm ratio, a critical step in generating appropriate proportions of endothelial and epithelial progenitors with tissue specificity. Single-cell RNA sequencing (scRNA-seq) revealed organ-specific gene signatures of endothelium and mesenchyme and identified key ligands driving endothelial specification. The endothelium exhibited tissue-specific barrier function, enhanced organoid maturation, cellular diversity, and alveolar formation on the engineered lung scaffold. Upon transplantation into mice, the organoid vasculature integrated with the host circulation while preserving organ specificity, further promoting organoid maturation. Leveraging these vascularized organoids, we uncovered abnormal endothelial-epithelial crosstalk in patients with forkhead box F1 (FOXF1) mutations. Multilineage organoids provide an advanced platform to study intricate cell-to-cell communications in human organogenesis and disease.
Keywords: FOXF1; co-differentiation; endoderm; intestine; lung; mesenchyme; mesoderm; organ-specific endothelium; organoid; vascularization.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests Cincinnati Children’s Hospital Medical Center has filed patent applications regarding the protocols for generating vascularized gut tube organoids. Y.S.Z. consulted for Allevi by 3D Systems and sits on the scientific advisory board and holds options of Xellar, neither of which participated in or biased the work. The relevant interests are managed by the Brigham and Women’s Hospital.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources